Join us for a webinar with
Dr. Bruce Gelb, MD FACS
Clinical transplant surgeon
NYU Langone Medical Center
In late 2019, SARS-CoV-2, the virus that causes COVID-19, began to rapidly spread around the world causing the global community to abruptly refocus on this current pandemic. This has stressed the ability to provide healthcare and driven dramatic resource shortages beyond just ICU beds and ventilators.
Bruce Gelb, a transplant surgeon in New York City, contracted COVID in early March 2020. Since recovering, he has been on the frontline, attending to the most critically ill patients in New York City. The virus has dramatically impacted the healthcare system. The ability to care for patients with non-COVID illnesses throughout the region, including organ transplants, cancer treatments, and elective surgeries have been seriously impacted.
Join us from 6:00 to 7:00 p.m. EST on Wednesday, May 27, for this special webinar with Bruce Gelb, MD, in which he will discuss his personal experiences, and how health systems and governments have variably addressed the pandemic, global healthcare challenges in managing a rapidly spreading new disease, strategies for managing shortages of resource and human expertise, disparities in the ability to provide and deliver care, and the pandemic’s impact on patients suffering from non-COVID medical conditions.
Guest Speaker
BRUCE GELB
Dr. Bruce Gelb, MD FACS is a clinical transplant surgeon who performs liver, kidney, pancreas, and living donor transplant surgery. He is a key member of the NYU Langone Health vascularized composite allograft (VCA) team and develops and manages immunosuppression regimens for face and hand transplant recipients. His patients have had the longest rejection free periods reported for face transplant recipients.
Dr. Gelb has served as the Chair of the Quality Improvement Committee of NYU Langone Health System. He has also served on the United Network for Organ Sharing (UNOS) Ethics Committee, the American Society of Transplant Surgeons (ASTS) Legislative Committee, and is a current member of the ASTS and UNOS Vascularized Composite Allograft (VCA) Committees.
He is concerned with a variety of issues in bioethics, with particular interest in the ethics of transplantation and organ donation. He is the immediate past-President and currently serves on the Board of Directors of the Global Bioethics Initiative, an NGO member of the United Nations Academic Impact with special consultative status with the UN Economic and Social Council (ECOSOC).
Dr. Gelb contracted COVID-19 in early March, and since recovering has been caring for the most critically ill coronavirus infected patients in New York City.